InsiderFlow

Mark Jeffrey DeLong

APLS

Mark Jeffrey DeLong serves as officer: Chief Business & Strat Officer at Apellis Pharmaceuticals, Inc. (APLS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

34 trades

$4.81M

Net Position

Net Seller

$4.81M

Companies Traded

1

APLS

Active Period

May 2021 – Feb 2026

34 total trades

Most Recent

Sell APLS

Feb 13, 2026 · $8.2K

Mark Jeffrey DeLong's Insider Trading at Apellis Pharmaceuticals, Inc. (APLS)

Buys

0 · $0.00

Sells

34 · $4.81M

Total Shares Bought

0

Total Shares Sold

93,448

APLS Price Chart
Loading chart...
DateTypeValue
Feb 13, 2026 Sell$8.2K
Feb 11, 2026 Sell$8.2K
Jan 23, 2026 Sell$73.4K
Jan 22, 2026 Sell$73.4K
Jan 21, 2026 Sell$26.4K
Jan 20, 2026 Sell$26.4K
Jan 15, 2026 Sell$39.5K
Jan 13, 2026 Sell$39.5K
Feb 11, 2025 Sell$10.4K
Jan 29, 2025 Sell$10.8K
Jan 22, 2025 Sell$42.5K
Jan 17, 2025 Sell$37.0K
Mar 18, 2024 Sell$564.0K
Feb 12, 2024 Sell$40.5K
Jan 22, 2024 Sell$90.0K
Jan 16, 2024 Sell$109.0K
Oct 23, 2023 Sell$6.0K
Feb 21, 2023 Sell$25.8K
Feb 10, 2023 Sell$34.3K
Jan 20, 2023 Sell$59.8K
Oct 20, 2022 Sell$11.4K
Aug 17, 2022 Sell$347.5K
Aug 11, 2022 Sell$335.0K
Aug 8, 2022 Sell$322.5K
Aug 4, 2022 Sell$607.5K
Jul 27, 2022 Sell$285.0K
Jul 19, 2022 Sell$282.1K
Jun 16, 2022 Sell$417.9K
Apr 20, 2022 Sell$367.7K
Feb 10, 2022 Sell$12.8K
Jul 21, 2021 Sell$65.0K
Jul 15, 2021 Sell$62.3K
Jun 15, 2021 Sell$259.8K
May 18, 2021 Sell$110.0K